X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs ORCHID PHARMA LTD - Comparison Results

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA ORCHID PHARMA LTD SHASUN PHARMA/
ORCHID PHARMA LTD
 
P/E (TTM) x 123.9 0.2 63,730.1% View Chart
P/BV x 8.5 0.2 3,707.0% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 SHASUN PHARMA   ORCHID PHARMA LTD
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
ORCHID PHARMA LTD
Sep-13
SHASUN PHARMA/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs94194 48.6%   
Low Rs4635 130.3%   
Sales per share (Unadj.) Rs214.2276.5 77.5%  
Earnings per share (Unadj.) Rs5.3-79.2 -6.7%  
Cash flow per share (Unadj.) Rs15.8-43.5 -36.4%  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %1.40-  
Book value per share (Unadj.) Rs53.353.9 98.9%  
Shares outstanding (eoy) m56.6270.45 80.4%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.30.4 78.8%   
Avg P/E ratio x13.1-1.4 -906.2%  
P/CF ratio (eoy) x4.4-2.6 -167.7%  
Price / Book Value ratio x1.32.1 61.7%  
Dividend payout %18.70-   
Avg Mkt Cap Rs m3,9588,067 49.1%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m2,1642,527 85.6%   
Avg. sales/employee Rs ThNM6,956.1-  
Avg. wages/employee Rs ThNM902.5-  
Avg. net profit/employee Rs ThNM-1,993.0-  
INCOME DATA
Net Sales Rs m12,12719,477 62.3%  
Other income Rs m229407 56.3%   
Total revenues Rs m12,35619,884 62.1%   
Gross profit Rs m1,0091,103 91.5%  
Depreciation Rs m5942,519 23.6%   
Interest Rs m4155,227 7.9%   
Profit before tax Rs m230-6,236 -3.7%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m-73-125 58.1%   
Profit after tax Rs m302-5,580 -5.4%  
Gross profit margin %8.35.7 147.0%  
Effective tax rate %-31.72.0 -1,576.9%   
Net profit margin %2.5-28.7 -8.7%  
BALANCE SHEET DATA
Current assets Rs m6,88411,014 62.5%   
Current liabilities Rs m8,45632,060 26.4%   
Net working cap to sales %-13.0-108.1 12.0%  
Current ratio x0.80.3 237.0%  
Inventory Days Days6295 65.0%  
Debtors Days Days10834 320.5%  
Net fixed assets Rs m4,97029,440 16.9%   
Share capital Rs m113705 16.1%   
"Free" reserves Rs m2,8752,043 140.7%   
Net worth Rs m3,0203,800 79.5%   
Long term debt Rs m1,8179,018 20.2%   
Total assets Rs m13,34746,510 28.7%  
Interest coverage x1.6-0.2 -804.3%   
Debt to equity ratio x0.62.4 25.4%  
Sales to assets ratio x0.90.4 217.0%   
Return on assets %5.4-0.8 -707.0%  
Return on equity %10.0-146.9 -6.8%  
Return on capital %13.3-3.7 -356.7%  
Exports to sales %46.437.9 122.4%   
Imports to sales %14.222.6 63.0%   
Exports (fob) Rs m5,6227,378 76.2%   
Imports (cif) Rs m1,7284,406 39.2%   
Fx inflow Rs m5,8437,513 77.8%   
Fx outflow Rs m2,1735,649 38.5%   
Net fx Rs m3,6691,865 196.8%   
CASH FLOW
From Operations Rs m3981,682 23.6%  
From Investments Rs m-1,635-9,860 16.6%  
From Financial Activity Rs m1,3096,644 19.7%  
Net Cashflow Rs m71-1,535 -4.6%  

Share Holding

Indian Promoters % 39.2 32.3 121.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 4.6 78.3%  
FIIs % 17.6 3.3 533.3%  
ADR/GDR % 0.0 4.6 -  
Free float % 39.6 55.3 71.6%  
Shareholders   20,750 84,811 24.5%  
Pledged promoter(s) holding % 12.3 54.9 22.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   PFIZER  ABBOTT INDIA  PANACEA BIOTECH  WYETH LTD  GSK PHARMA  

Compare SHASUN PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Volatile Day in Red; Pharma Stocks Lose Most(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a negative note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA - UNICHEM LAB COMPARISON

COMPARE SHASUN PHARMA WITH

MARKET STATS